BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 18069598)

  • 1. [New strategies in the treatment of atrial fibrillation].
    Tamargo Menéndez J
    An R Acad Nac Med (Madr); 2007; 124(2):305-16; discussion 316-8. PubMed ID: 18069598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drug treatment of atrial fibrillation].
    Janko S; Hoffmann E
    MMW Fortschr Med; 2006 Apr; 148(15):32-5. PubMed ID: 16711199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Non-channel drugs to prevent atrial fibrillation].
    Fazekas T; Liszkai G
    Orv Hetil; 2005 Nov; 146(45):2287-94. PubMed ID: 16304807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial fibrillation and heart failure: natural history and pharmacological treatment.
    Savelieva I; John Camm A
    Europace; 2004 Sep; 5 Suppl 1():S5-19. PubMed ID: 15450275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trials, the renin angiotensin system and atrial fibrillation.
    Birnie DH; Gollob M; Healey JS
    Curr Opin Cardiol; 2006 Jul; 21(4):368-75. PubMed ID: 16755207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
    Makkar KM; Sanoski CA; Spinler SA
    Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug therapy for atrial fibrillation.
    Conway EL; Musco S; Kowey PR
    Cardiol Clin; 2009 Feb; 27(1):109-23, ix. PubMed ID: 19111768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-antiarrhythmic drugs in atrial fibrillation: a review of non-antiarrhythmic agents in prevention of atrial fibrillation.
    Lally JA; Gnall EM; Seltzer J; Kowey PR
    J Cardiovasc Electrophysiol; 2007 Nov; 18(11):1222-8. PubMed ID: 17553070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacologic treatment of atrial fibrillation].
    Lelakowski J
    Pol Merkur Lekarski; 2008 Oct; 25(148):303-8. PubMed ID: 19145926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrical remodeling in atrial fibrillation.
    Dobrev D
    Herz; 2006 Apr; 31(2):108-12; quiz 142-3. PubMed ID: 16738832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathophysiology of the renin-angiotensin-system in atrial fibrillation].
    Heusch G; Schulz R
    Dtsch Med Wochenschr; 2006 Apr; 131(15):817-20. PubMed ID: 16607602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers in atrial fibrillation.
    Levine MJ; Schweitzer P
    Vnitr Lek; 2010 Nov; 56(11):1138-41. PubMed ID: 21247007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy of renin angiotensin system inhibitors and bepridil is useful for maintaining sinus rhythm in patients with atrial fibrillation.
    Kawamura M; Ito H; Onuki T; Miyoshi F; Minoura Y; Asano T; Tanno K; Kobayashi Y
    J Cardiol; 2007 Dec; 50(6):343-50. PubMed ID: 18186308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Are ACE inhibitors and angiotensin receptor blockers useful in the treatment of atrial fibrillation?].
    Raatikainen MJ; Huikuri HV
    Duodecim; 2003; 119(16):1505-7. PubMed ID: 14535023
    [No Abstract]   [Full Text] [Related]  

  • 15. [The clinical challenge of the atrial fibrillation].
    de Berrazueta Fernández JR
    An R Acad Nac Med (Madr); 2007; 124(2):361-78. PubMed ID: 18069601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of atrial remodeling and clinical relevance.
    Nattel S; Shiroshita-Takeshita A; Cardin S; Pelletier P
    Curr Opin Cardiol; 2005 Jan; 20(1):21-5. PubMed ID: 15596955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upstream therapy of atrial fibrillation.
    Smit MD; Van Gelder IC
    Expert Rev Cardiovasc Ther; 2009 Jul; 7(7):763-78. PubMed ID: 19589113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upstream effect for atrial fibrillation: still a dilemma?
    Calò L; Martino A; Sciarra L; Ciccaglioni A; De Ruvo E; De Luca L; Sette A; Giunta G; Lioy E; Fedele F
    Pacing Clin Electrophysiol; 2011 Jan; 34(1):111-28. PubMed ID: 21029134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins and polyunsaturated fatty acids for treatment of atrial fibrillation.
    Savelieva I; Camm J
    Nat Clin Pract Cardiovasc Med; 2008 Jan; 5(1):30-41. PubMed ID: 18094671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial fibrillation and renin-angiotensin system.
    Serra JL; Bendersky M
    Ther Adv Cardiovasc Dis; 2008 Jun; 2(3):215-23. PubMed ID: 19124423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.